Accumulation in Pharma Stocks Signals Possible Upside ?

Pharma stocks are once again drawing attention as the sector shows signs of accumulation after a long consolidation phase. Many frontline names have begun to attract fresh buying interest, supported by stable earnings, strong export demand, and opportunities in the US generics market. Domestic formulations continue to provide steady growth, while API and specialty products are improving margins. Technically, several pharma counters are trading near demand zones, suggesting the possibility of a broader sectoral up-move. With defensive characteristics and resilience in uncertain global markets, pharma may emerge as a preferred sector for investors in the near term, especially if momentum sustains above key resistance levels. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link *****